Cite

HARVARD Citation

    Xing, P. et al. (2019). Co‐mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancer. Journal of cellular and molecular medicine. 23 (10), pp. 6812-6821. [Online]. 
  
Back to record